Purchase order 4800191561

The University of Nebraska Medical Center, a state agency under the Board of Regents of the University of Nebraska, awarded a purchase order to Cell Signaling Technology Inc., based in Boston, Massachusetts, for research-grade antibody products. The contract, designated 4800191561, was executed on April 1, 2026, with a completion date of April 8, 2026, for a total contract value of $956. The award encompasses two phosphorylated receptor tyrosine kinase antibodies: Phospho-HER2/ErbB2 (Tyr1196) (D66B7) Rabbit antibody (material number 6942S) at $474.00 and Phospho-HER3/ErbB3 (Tyr1289) (D1B5) Rabbit antibody (material number 2842S) at $482.00.

Delivery of the goods is required to the University of Nebraska Medical Center's Shipping and Receiving facility in Omaha, Nebraska, on a free-on-board destination basis with freight prepaid by the vendor. The purchase order is issued under the Standard Terms of Purchase established by the State of Nebraska and is exempt from sales tax under the University's exemption number 05-8905401. Payment terms are Net 30 days from invoice. The vendor is required to acknowledge acceptance of the purchase order within ten days and provide all documentation with packing slips and purchase order number references on invoices.